Scott Braunstein
InvestorOperating Partner at Aisling Capital Β· Vice-Chairman of the Board and Director; Science and Technology Committee, Co-Chair; Audit Committee, Member at atai Life Sciences Β· Vice Chair Board of Directors at AtaiBeckley
Miami, Florida, United States
Find your path to Scott
158 people in our graph share verified history with Scott β schools, employers, funds. One of them is your warm intro.
About
Scott Braunstein is an operating partner at Aisling Capital and serves on the boards of Caribou Biosciences and Trevena. He previously led Marinus Pharmaceuticals as CEO and Chairman, was COO at Pacira Pharmaceuticals, and managed the JP Morgan Global Healthcare Fund. He started his career as a practicing physician at Summit Medical Group, holds a medical degree from Albert Einstein College of Medicine, and an undergraduate degree from Cornell University.
Invests in
Biotech
Experience
- Nortiva BioScientific Advisorcurrent2026 β present
- AtaiBeckleyVice Chair Board of Directorscurrent2025 β presentSan Diego, California, United States
- AtaiBeckleyBoard Member2024 β 2025United States
- Ray Therapeutics, Inc.Chairmancurrent2025 β presentSan Francisco Bay Area
- Miami Biotech CollectiveBoard Membercurrent2025 β present
- One BiosciencesBoard Membercurrent2024 β presentParis, Γle-de-France, France
- Caribou BiosciencesBoard Membercurrent2022 β presentUnited States
- Aisling CapitalOperating Partnercurrent2015 β presentNew York, New York
- Bent Water Brewing CoBoard Membercurrent2015 β presentLynn, Massachusetts
- RAPT TherapeuticsBoard Member2025 β 2026San Francisco Bay Area
- SiteOne Therapeutics Inc.Board Member2018 β 2026Bozeman, Montana
- Marinus PharmaChairman and Chief Executive Officer2022 β 2025Radnor, Pennsylvania, United States
- Marinus PharmaChief Executive Officer2019 β 2025Pennsylvania
- Marinus PharmaBoard Member2018 β 2025Radnor PA
- Trevena, Inc.Board Member2018 β 2025Chesterbrook PA
- Constellation PharmaceuticalsBoard Member2019 β 2022Cambridge, Massachusetts
- Ziopharm OncologyBoard Member2018 β 2020Boston, Massachusetts
- Protara TherapeuticsExecutive Chairman2018 β 2020New York, New York
- Esperion - The Lipid Management CompanyBoard Member2015 β 2020Ann Arbor, Michigan
- Pacira Pharmaceuticals, Inc.COO2015 β 2018
- JPMorgan Chase & Co.Portfolio Manager2002 β 2014New York
- Summit Medical Group of New JerseyPartner1994 β 1999Short Hills, New Jersey
- Albert Einstein College of MedicineAssistant Clinical Professor Medicine1993 β 1994Bronx, New York
Skills & more
From Scott's professional profile.
Investments
Board seats
Caribou Biosciences, Inc.Trevena Inc.
Per the firm's website.
Colleagues at Aisling Capital
Frequently asked questions
- Who is Scott Braunstein?
- Scott Braunstein is an operating partner at Aisling Capital and serves on the boards of Caribou Biosciences and Trevena. He previously led Marinus Pharmaceuticals as CEO and Chairman, was COO at Pacira Pharmaceuticals, and managed the JP Morgan Global Healthcare Fund. He started his career as a practicing physician at Summit Medical Group, holds a medical degree from Albert Einstein College of Medicine, and an undergraduate degree from Cornell University.
- Where does Scott Braunstein work?
- Scott Braunstein is Operating Partner at Aisling Capital.
- What does Scott Braunstein invest in?
- Scott Braunstein invests in Biotech.
- What boards does Scott Braunstein sit on?
- Scott Braunstein holds tracked board seats at Caribou Biosciences, Inc., Trevena Inc..
- Where did Scott Braunstein go to school?
- Scott Braunstein studied at Albert Einstein College of Medicine (Doctor of Medicine - MD); Cornell University (Bachelor of Applied Science - BASc, Biology).
Same school
Also attended Albert Einstein College of Medicine11
+ 5 more
Also attended Cornell University1,165
+ 1,159 more
Shared employers
Also worked at AtaiBeckley11
+ 5 more
Also worked at Miami Biotech Collective2
Also worked at Marinus Pharma2
Also worked at JPMorgan Chase & Co.553
+ 547 more












































